Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Stem Cell Reports|April 22, 2022
Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in JapanTaichi Hatta, Kazuki Ide, Misao Fujita, et al.
Frontiers in Genetics|September 4, 2023
Human genome editing in clinical applications: Japanese lay and expert attitudesTsutomu Sawai, Taichi Hatta, Kyoko Akatsuka, et al.
BMC Medical Ethics|September 12, 2022
Current status of umbilical cord blood storage and provision to private biobanks by institutions handling childbirth in JapanMaho Murata, Kenichiro Kawabe, Taichi Hatta, et al.
Interactive Journal of Medical Research|May 26, 2016
Evaluating the Quality of Website Information of Private-Practice Clinics Offering Cell Therapies in JapanHidenori Kashihara, Takeo Nakayama, Taichi Hatta, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 25, 2025
Oncologists' Views and Communication Practices Regarding Unproven High-Cost Cancer Interventions in Private Medical Practice: A Questionnaire SurveyTsunakuni Ikka, Taichi Hatta, Noriyuki Katsumata, et al.
BMC Health Services Research|April 11, 2026
Evolving determinants of implementing low-risk childbirth quality improvement in Japan: a longitudinal qualitative studyMai Takeshita, Kayo Ueda, Ayako Kohno, et al.
BMC Medical Informatics and Decision Making|February 20, 2016
Measuring motivation for medical treatment: confirming the factor structure of the Achievement Motivation Index for Medical Treatment (AMI-MeT)Taichi Hatta, Keiichi Narita, Keiichi Naria, et al.
Breast Cancer (Dove Medical Press)|August 15, 2019
Beliefs held by breast surgeons that impact the treatment decision process for advanced breast cancer patients: a qualitative studyReina Ozeki-Hayashi, Misao Fujita, Atsushi Tsuchiya, et al.
Biopsychosocial Medicine|August 20, 2022
Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional studyHiroyuki Sato, Misao Fujita, Atsushi Tsuchiya, et al.
Stem Cell Reports|February 24, 2023
Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in JapanTsunakuni Ikka, Misao Fujita, Taichi Hatta, et al.
Pageof 3